Efficacy and Safety of 4-Months Rifapentine-Moxifloxacin Treatment of Tuberculosis in Patients with Diabetes
Year: 2024
Type: preprint
Source: SSRN Electronic Journal
DOI: 10.2139/ssrn.4967259
Authors: Ekaterina V. Kurbatova, William C. Whitworth, Lakshmi Praveena Peddareddy, Patrick PJ Phillips, Nigel A. Scott, Kia E. Bryant, Rodney Dawson, Sandra Wagner Cardoso, Wadzanai Samaneka, Melissa Engle, Ziyaad Waja, Erin Sizemore, Wendy Carr, Kelly E. Dooley, Radojka M. Savic, Susan Swindells, Richard E. Chaisson, Susan E. Dorman, Payam Nahid, Nhung Viet Nguyen
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4402858186